Association between gestational trophoblastic disease (GTD) history and clinical outcomes in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles

Reprod Biol Endocrinol. 2022 Feb 4;20(1):27. doi: 10.1186/s12958-022-00898-2.


Background: Gestational trophoblastic disease (GTD) usually affects young women of childbearing age. After treatment for GTD, 86% of women wish to achieve pregnancy. On account of the impacts of GTD and treatments as well as patient anxiety, large numbers of couples turn to assisted reproductive technology (ART), especially in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI). But few studies have investigated whether a history of GTD affects the outcomes of IVF/ICSI in secondary infertile patients and how it occurs. We investigate whether a history of GTD affects the IVF/ICSI outcomes and the live birth rates in women with secondary infertility.

Methods: This retrospective cohort study enrolled 176 women with secondary infertility who underwent IVF/ICSI treatment at the reproductive medical center of Nanjing Drum Tower Hospital from January 1, 2016, to December 31, 2020. Participants were divided into the GTD group (44 women with GTD history) and control group (132 women without GTD history matched from 8318 secondary infertile women). The control group and the study group were matched at a ratio of 3:1 according to patient age, infertility duration, number of cycles and body mass index (BMI). We assessed retrieved oocytes and high-grade embryos, biochemical pregnancy, miscarriage, ectopic pregnancy, gestational age at delivery, delivery mode and live birth rates.

Result(s): We found a significantly reduced live-birth rate (34.1% vs 66.7%) associated with IVF/ICSI cycles in patients with a GTD history compared to those without a GTD history. The biochemical pregnancy and miscarriage rates of the GTD group were slightly higher than those of the control group. In addition, there was a difference in gestational age at delivery between the GTD and control groups (p < 0.001) but no differences in the mode of delivery (p = 0.267). Furthermore, the number of abandoned embryos in the GTD group was greater than that in the control group (p = 0.018), and the number of good-quality embryos was less than that in the control group (p = 0.019). The endometrial thickness was thinner (p < 0.001) in the GTD group. Immunohistochemistry (IHC) showed abnormal endometrial receptivity in the GTD group.

Conclusion(s): The GTD history of patients undergoing IVF/ICSI cycles had an impact on the live-birth rate and gestational age at delivery, which might result from the thinner endometrium and abnormal endometrial receptivity before embryo transfer.

Keywords: GTD history; IVF/ICSI; endometrial receptivity; gestational age at delivery; live-birth rate.

MeSH terms

  • Abortion, Spontaneous / diagnosis
  • Abortion, Spontaneous / epidemiology
  • Abortion, Spontaneous / etiology
  • Abortion, Spontaneous / therapy
  • Adult
  • Birth Rate
  • China / epidemiology
  • Cohort Studies
  • Female
  • Fertilization in Vitro / methods*
  • Gestational Trophoblastic Disease / complications
  • Gestational Trophoblastic Disease / diagnosis
  • Gestational Trophoblastic Disease / epidemiology*
  • Gestational Trophoblastic Disease / therapy*
  • Humans
  • Infant, Newborn
  • Infertility, Female / diagnosis
  • Infertility, Female / epidemiology
  • Infertility, Female / etiology
  • Infertility, Female / therapy*
  • Male
  • Pregnancy
  • Pregnancy Rate*
  • Prognosis
  • Reproductive History
  • Retrospective Studies
  • Sperm Injections, Intracytoplasmic
  • Treatment Outcome